LEVITRONIX CENTRIMAG PRIMARY CONSOLE— 510(k) K053630

Substantially Equivalent

Levitronix, LLC

FDA 510(k) clearance K053630 for LEVITRONIX CENTRIMAG PRIMARY CONSOLE, Substantially Equivalent on 2006-01-26. Applicant: Levitronix, LLC.

Clearance details

Applicant: Levitronix, LLC
Product code: Code DWA
Advisory panel: Cardiovascular
Date received: 2005-12-29
Decision date: 2006-01-26
Decision: Substantially Equivalent
Clearance type: Special
Location: Waltham, MA, US

Download summary PDF View on FDA.gov ↗

Adverse events under product code DWA

product code DWA

Death: 15
Malfunction: 1,654
Total: 1,669

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.